Maliha Zahid
Overview
Explore the profile of Maliha Zahid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
978
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bibi R, Zahid M, Rasool F, Tariq M, Hussain A, Asif H, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2024 Dec;
330:125630.
PMID: 39732534
The ruthenium compounds have been known to have the wide range of potential applications as anticancer, antibacterial and anti-diabetic etc. The ligand substitutions play a vital role in enhancing the...
2.
Lopuszynski J, Wang J, Zahid M
Molecules
. 2024 Sep;
29(17).
PMID: 39274936
One of the bottlenecks to bringing new therapies to the clinic has been a lack of vectors for delivering novel therapeutics in a targeted manner. Cell penetrating peptides (CPPs) have...
3.
Sahagun D, Lopuszynski J, Feldman K, Pogodzinski N, Zahid M
Pharmaceutics
. 2024 Jan;
16(1).
PMID: 38258084
Targeted delivery of therapeutics specifically to cardiomyocytes would open up new frontiers for common conditions like heart failure. Our prior work using a phage display methodology identified a 12-amino-acid-long peptide...
4.
Sahagun D, Zahid M
Biomolecules
. 2023 Dec;
13(12).
PMID: 38136562
Despite significant strides in prevention, diagnosis, and treatment, cardiovascular diseases remain the number one cause of mortality in the United States, with rates climbing at an alarming rate in the...
5.
Zahid M, Weber B, Yurko R, Islam K, Agrawal V, Lopuszynski J, et al.
Pharmaceutics
. 2023 Aug;
15(8).
PMID: 37631321
Background: Amiodarone is underutilized due to significant off-target toxicities. We hypothesized that targeted delivery to the heart would lead to the lowering of the dose by utilizing a cardiomyocyte-targeting peptide...
6.
Glessner J, Ningappa M, Ngo K, Zahid M, So J, Higgs B, et al.
J Hepatol
. 2023 Aug;
79(6):1385-1395.
PMID: 37572794
Background & Aims: Biliary atresia (BA) is poorly understood and leads to liver transplantation (LT), with the requirement for and associated risks of lifelong immunosuppression, in most children. We performed...
7.
Yurko R, Islam K, Weber B, Salama G, Zahid M
Front Chem
. 2023 Aug;
11:1220573.
PMID: 37547910
Modern medicine has developed a myriad of therapeutic drugs against a wide range of human diseases leading to increased life expectancy and better quality of life for millions of people....
8.
Zahid M, Weber B, Yurko R, Islam K, Agrawal V, Lopuszynski J, et al.
bioRxiv
. 2023 May;
PMID: 37214919
Background: Amiodarone is underutilized due to significant off-target toxicities. We hypothesized that targeted delivery to the heart would lead to lowering of dose by utilizing a cardiomyocyte targeting peptide (CTP),...
9.
Gallicano G, Fu J, Mahapatra S, Sharma M, Dillon C, Deng C, et al.
Pharmaceuticals (Basel)
. 2022 Jul;
15(7).
PMID: 35890169
Causes and treatments for heart failure (HF) have been investigated for over a century culminating in data that have led to numerous pharmacological and surgical therapies. Unfortunately, to date, even...
10.
Teekakirikul P, Zhu W, Xu X, Young C, Tan T, Smith A, et al.
Cell Rep Med
. 2022 Mar;
3(2):100501.
PMID: 35243414
Analysis of large-scale human genomic data has yielded unexplained mutations known to cause severe disease in healthy individuals. Here, we report the unexpected recovery of a rare dominant lethal mutation...